EDWARDS LIFESCIENCES CORP (EW) Stock News
NYSE:EW - New York Stock Exchange, Inc. - US28176E1082 - Common Stock - Currency: USD
EW Latest News, Press Relases and Analysis
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
What's going on in today's session: S&P500 movers
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.
Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens
Edwards Lifesciences raised 2025 revenue forecast after Q1 results beat EPS estimates and TMTT sales jumped 58% amid strong global demand.
This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Thursday's pre-market session: top gainers and losers in the S&P500 index
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Edwards Lifesciences (EW) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Edwards Lifesciences (EW) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat
Edwards Lifesciences stock was flat late Wednesday after the medtech company beat profit views and delivered in-line sales.
Mentions: LLY
Edwards Lifesciences Reports First Quarter Results
Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings
EW's first-quarter 2025 performance is likely to have gained from growth drivers across its businesses amid macroeconomic headwinds.
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities
Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S. companies that are leading the way in crucial areas of positive structural transformation within the economy. The fund returned 8.8% (net) in the fourth […]
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
Jim Cramer Calls Edwards Lifesciences (EW) a Hold – Prefers Boston Scientific Right Now!
We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where Edwards Lifesciences (NYSE:EW) stands against other stocks that Jim Cramer put under a microscope. On Thursday, Jim Cramer, the host of Mad Money, shared his thoughts on the […]
Mentions: BSX
Is Taiwan Semiconductor Manufacturing Company Limited (TSM) the Best Very Cheap Stock to Buy According to Billionaires?
We recently published a list of 10 Best Very Cheap Stocks to Buy According to Billionaires In this article, we are going to take a look at where Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) stands against other best very cheap stocks to buy according to billionaires. Coming off 2 years of healthy broader market performance (~26% total […]
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
EDWARDS LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW
/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that...
Edwards Beats Fourth-Quarter Forecasts, But Shares Slip
Edwards Lifesciences stock fell slightly late Tuesday after the company kept its outlook for 2025 despite beating forecasts.